Geneoscopy: Funding, Investors & Team (Oct 2026)
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently, there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.
Geneoscopy has raised $210M across 2 funding rounds on record, the most recent a Series C of $105M announced in Jan 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Geneoscopy Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Geneoscopy Funding Rounds
Geneoscopy raised $105M in a Series B announced in Nov 2021.
3.2 years later, a Series C of $105M was announced in Jan 2025.
Geneoscopy Founders and Leadership Team
Contact details for the Geneoscopy team: 1 of 1 has an email address on file.
Start 14-day free trial →Geneoscopy Funding Compared to Other Biotechnology Startups
Geneoscopy's latest round of $105M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Geneoscopy in Biotechnology and Saint Louis
Companies Similar to Geneoscopy
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Geneoscopy Funding FAQs
What does Geneoscopy do?
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently, there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.
How much funding has Geneoscopy raised?
Geneoscopy has raised $210M across 2 rounds on record. The most recent is a Series C of $105M announced in Jan 2025.
When did Geneoscopy last raise funding?
Geneoscopy's most recent funding round on record is a Series C of $105M, announced in Jan 2025.
Who founded Geneoscopy?
FundedIQ lists Erica Barnell (Founder) at Geneoscopy.
Where is Geneoscopy headquartered?
Geneoscopy is based in Saint Louis, Missouri, United States.
How many employees does Geneoscopy have?
Geneoscopy is in the 11-50 employee band.
How does Geneoscopy's funding compare to other Biotechnology startups?
Geneoscopy's latest round of $105M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Geneoscopy Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Geneoscopy is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.